Corza Health acquires TachoSil surgical patch from Takeda for $422.4M

Takeda completed the sale of its TachoSil Fibrin Sealant Patch to Corza Health for €350 million ($422.4 million) in cash. The deal includes assets and licenses for development and commercialization, while Takeda retains the manufacturing facility in Linz, Austria.

“Takeda remains focused on executing its long-term growth strategy to optimise our business mix around our key business areas, and simplifying our operations to better serve patients by delivering innovative treatments in these areas.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comTakeda sells TachoSil surgical patch to Corza Health for $422.4mFeb 2, 2021

Summarized from public sources; check the original articles before acting on it.